Intrinsic Value of S&P & Nasdaq Contact Us

Pasithea Therapeutics Corp. KTTA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
60/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+315.5%

Pasithea Therapeutics Corp. (KTTA) has 12 identified peers for comparison in the Healthcare sector. Peers include ABVC, BTTX, BWV, ELYM, FBRX, HILS and others.

KTTA has a market capitalization of $5.37M, compared to an average peer market cap of $84.16M. KTTA is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message